Sonodynamic therapy has attracted wide attention as a noninvasive therapy due to deep tissue penetration. However, the majority of sonosensitizers often suffer from poor physiological stability, rapid blood clearance and...

The synergistic nanotheranostics of reactive oxygen species (ROS) augment or phototherapy has been a promising method within synergistic oncotherapy. However, it is still hindered by sophisticated design and fabrication, lack of a multimodal synergistic effect, and hypoxia-associated poor photodynamic therapy (PDT) efficacy. Herein, a kind of porous shuttle-shape platinum (IV) methylene blue (Mb) coordination polymer nanotheranostics-loaded 10-hydroxycamptothecin (CPT) is fabricated to address the abovementioned limitations. Our nanoreactors possess spatiotemporally controlled O2 self-supply, self-sufficient singlet oxygen (1O2), and outstanding photothermal effect. Once they are taken up by tumor cells, nanoreactors as a cascade catalyst can efficiently catalyze degradation of the endogenous hydrogen peroxide (H2O2) into O2 to alleviate tumor hypoxia. The production of O2 can ensure enhanced PDT. Subsequently, under both stimuli of external red light irradiation and internal lysosomal acidity, nanoreactors can achieve the on-demand release of CPT to augment in situ mitochondrial ROS and highly efficient tumor ablation via phototherapy. Moreover, under the guidance of near-infrared (NIR) fluorescent imaging, our nanoreactors exhibit strongly synergistic potency for treatment of hypoxic tumors while reducing damages against normal tissues and organs. Collectively, shuttle-shape platinum-coordinated nanoreactors with augmented ROS capacity and enhanced phototherapy efficiency can be regarded as a novel tumor theranostic agent and further promote the research of synergistic oncotherapy.

No abstract

Although nanotheranostics have displayed striking potential toward precise nanomedicine, their targeting delivery and tumor penetration capacities are still impeded by several biological barriers. Besides, the current antitumor strategies mainly focus on killing tumor cells rather than antiangiogenesis. Enlightened by the fact that the smart transformable self-targeting nanotheranostics can enhance their targeting efficiency, tumor penetration, and cellular uptake, we herein report carrier-free Trojan-horse diameter-reducible metal−organic nanotheranostics by the coordination-driven supramolecular sequential co-assembly of the chemodrug pemetrexed (PEM), transition-metal ions (Fe III ), and antiangiogenesis pseudolaric acid B. Such nanotheranostics with both a high dual-drug payload efficiency and outstanding physiological stability are responsively decomposed into numerous ultra-small-diameter nanotheranostics under stimuli of the moderate acidic tumor microenvironment and then internalized into tumor cells through tumor-receptor-mediated self-targeting, synergistically enhancing tumor penetration and cellular uptake. Besides, such nanotheranostics enable visualization of self-targeting capacity under the macroscopic monitor of computed tomography/magnetic resonance imaging, thereby realizing efficient oncotherapy. Moreover, tumor microvessels are precisely monitored by optical coherence tomography angiography/laser speckle imaging during chemo-antiangiogenic therapy in vivo, visually verifying that such nanotheranostics possess an excellent antiangiogenic effect. Our work will provide a promising strategy for further tumor diagnosis and targeted therapy.

No abstract

No abstract

No abstract

Optical sensing methods are especially attractive due to their low cost, rapid detection, and high sensitivity. Due to multiple enzyme‐mimetic activities, fast electron transfer capability, and biological molecules affinity, cerium oxide nanoparticle (CNP) represents a promising candidate to be used as the recognition and/or transducer element in optical biosensors. Despite the significant achievements of CNPs as therapeutic agents, the applications of CNPs as sensing elements are still in their infancy. To deepen the understanding and promote the development of CNP‐based optical biosensing, in this review, the ingenious design and fabrication of CNP‐based optical sensors are introduced, and the underlying sensing mechanisms are in‐depth analyzed. Furthermore, recent advances in CNP‐based optical sensing strategies for biomarker detection, disease diagnosis, and therapy are intensively discussed. Finally, current challenges and potential solutions of CNP‐based optical sensors for effective in vivo sensing are outlined.